ProCE Banner Activity

When Do You Consider Therapy for Patients With Smoldering Multiple Myeloma?


Download these slides from a live symposium for an overview of considerations for risk assessment and treatment of smoldering myeloma therapy.

Released: December 18, 2023



Jesús F. San-Miguel

Jesús F. San-Miguel

Professor of Medicine
Senior Consultant
Cancer Center Clínica Universidad de Navarra
Pamplona, Spain

Provided by

Provided by Clinical Care Options, LLC in partnership with the International Myeloma Foundation.

ProCE Banner


Supported by educational grants from Karyopharm Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc

Sanofi Genzyme


International Myeloma Foundation

ProCE Banner